Vizsgálati helyszín
LTD "New Hospitals"
Tbilisi, 0114, GrúziaMég nincs intézményhez kötve
- 20futó vizsgálat
- 1lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 21 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis11 vizsgálat
- 2. fázis6 vizsgálat
- 2/3. fázis2 vizsgálat
- 1. fázis1 vizsgálat
- 4. fázis1 vizsgálat
- Állapot
- Fut, nem toboroz14 vizsgálat
- Toboroz6 vizsgálat
- Lezárult1 vizsgálat
- Fő szponzor
- Regeneron Pharmaceuticals6 vizsgálat
- argenx2 vizsgálat
- Ipsen2 vizsgálat
- SystImmune Inc.2 vizsgálat
- Aphaia Pharma US LLC1 vizsgálat
- és még 8
Futó vizsgálatok
Toboroz
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
NCT07625644· 3. fázis· SystImmune Inc.· Forrás
Contact: David Giorgadze (principal investigator)
Toboroz
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630· 3. fázis· argenx· Forrás
Contact: Temur Margania, MD
Toboroz
A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities
NCT07008456· 2. fázis· Aphaia Pharma US LLC· Forrás
Contact: Lia Katcharava, MD Prof.
Toboroz
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
NCT07080242· 1. fázis· SystImmune Inc.· Forrás
Contact: Mariam Kistauri
Toboroz
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
NCT06532006· 3. fázis· Shanghai Henlius Biotech· Forrás
Contact: Ying Li
Fut, nem toboroz
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
NCT06161441· 2. fázis· Regeneron Pharmaceuticals· Forrás
Toboroz
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
NCT06414954· 2. fázis· NMD Pharma A/S· Forrás
Contact: NMD Pharma A/S
Toboroz
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
NCT06095583· 3. fázis· Shanghai Junshi Bioscience Co., Ltd.· Forrás
Contact: Davit Giorgadze
Fut, nem toboroz
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults
NCT06047444· 3. fázis· Ipsen· Forrás
Fut, nem toboroz
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults
NCT06047457· 3. fázis· Ipsen· Forrás
Fut, nem toboroz
A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
NCT05800015· 2/3. fázis· Regeneron Pharmaceuticals· Forrás
Fut, nem toboroz
A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)
NCT05557591· 2. fázis· Regeneron Pharmaceuticals· Forrás
Fut, nem toboroz
A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003)
NCT05816252· 2. fázis· Klus Pharma Inc.· Forrás
Fut, nem toboroz
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
NCT05611931· 3. fázis· Karyopharm Therapeutics Inc· Forrás
Fut, nem toboroz
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
NCT05608291· 3. fázis· Regeneron Pharmaceuticals· Forrás
Fut, nem toboroz
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
NCT05352672· 3. fázis· Regeneron Pharmaceuticals· Forrás
Fut, nem toboroz
THIO Sequenced With Cemiplimab in Advanced NSCLC
NCT05208944· 2. fázis· Maia Biotechnology· Forrás
Fut, nem toboroz
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
NCT05070858· 3. fázis· Regeneron Pharmaceuticals· Forrás
Fut, nem toboroz
Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
NCT05134441· 3. fázis· Immunic AG· Forrás
Fut, nem toboroz
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease
NCT04929210· 4. fázis· Janssen Research & Development, LLC· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Hibát jelzek